Strategy
Portfolio
People
Careers
March 8, 2018
MyoKardia steps closer to the launch of a groundbreaking heart trial after finding its low-dose starting point
Back
Portfolio News
Next
Back
Blog
Next
News
Blog
Foresite Labs
Contact Us
Home
Strategy
Portfolio
People
Careers
News
Blog
Foresite Labs
Contact
Investor Login
Terms
Privacy Policy
©2022 Foresite Capital Management, LLC
Site by Goodlab